FOLLOW US

All Anaplastic Thyroid Cancer Articles

Macrocephaly points to likelihood of PTEN mutation in follicular thyroid cancer patients
Among people with a mutation of a particular gene called PTEN, the rate of differentiated thyroid cancer (DTC) is between 3 and 10 percent, but until recently, researchers had not tabulated how many patients with follicular thyroid cancer (FTC) typically display the mutation.
Studies summarize promising innovations in molecular diagnosis of thyroid cancer
Two recently released studies, one written by a pair of Greek endocrinologists and the other by an American pathologist, summarize the latest advancements made into the molecular analysis and diagnosis of thyroid cancer.
Researchers assess causes of death among those who succumb to well-differentiated thyroid cancer
While well-differentiated thyroid cancer (WDTC) tends to have a high post-surgical survival rate, individuals who have been treated for this form of thyroid disease occasionally die nonetheless, and a team of New York researchers recently attempted to determine the reasons why.
Genetic changes in thyroid cancer block vitamin D3 absorption in tumor cells
A recent letter to the editor of the journal Thyroid commented on the apparent connection between papillary thyroid cancer (PTC) and the overexpression of the CYP24A1 gene, which codes for enzymes that deactivate vitamin D3.
Study examines occult medullary thyroid cancer
Medullary thyroid cancer (MTC) is a relatively rare form of thyroid disease, one that is often difficult to detect, which is one reason why scientists at the Johns Hopkins University School of Medicine recently attempted to quantify the rate at which MTC goes undiscovered until a thyroidectomy.
Studies recommend maintaining current protocol for radioactive iodine treatment of thyroid cancer
Though a significant body of research recommends that all patients who have been given radioactive iodine 131 (I-131) for thyroid cancer be hospitalized overnight, two new studies suggest keeping the procedure outpatient.
Case report describes misdiagnosis of papillary thyroid cancer
The importance of correctly pinpointing papillary thyroid cancer (PTC) was recently highlighted in a case report describing the misdiagnosis of the disease as carcinoma of the lungs.
Medicines may one day target papillary thyroid cancer based on its genetic source
Given that thyroid cancer is a disease that originates in mutations of DNA, an Italian researcher recently reviewed the state of genomic medicine, a healthcare field that has the potential to treat malignancies at the genetic level.
In mildest cases of thyroid cancer, radioactive iodine therapy may be unnecessary
While radioactive iodine is routinely prescribed to treat many forms of thyroid cancer, a group of New York researchers stated that this therapy may be unnecessary or even dangerous among patients with the mildest forms of the disease.
Genetic analysis spots hereditary cases of medullary thyroid cancer
A significant percentage of medullary thyroid cancer (MTC) cases are hereditary, caused by a genetic mutation that researchers recently sought while examining the DNA of Middle Eastern adults with apparently sporadic cases of the disease.
Study establishes epidemiology of thyroid cancer by type, demographic group
Researchers from the National Cancer Institute (NCI) and several U.S. universities recently analyzed state-based thyroid cancer data in order to determine the incidence of each variety of the disease among American demographic groups.
Medullary thyroid cancer may literally be 'a pain in the neck'
It can be difficult to detect the presence of medullary thyroid cancer (MTC), but new research suggests that individuals with neck pain are more likely than those without it to have an advanced case of the disease.
Minimally invasive surgery for thyroid disease may be fit for children
Research conducted at Georgia Health Sciences University indicates that minimally invasive surgery for thyroid disease, a procedure once only used among adults, appears to have few complications for children and teens.
What is diffuse sclerosing papillary thyroid cancer? Rare and dangerous, experts say
Papillary thyroid cancer (PTC) is the thyroid gland's most common and treatable carcinoma, but new research has outlined a rare but much more serious variant of this disease.
FDA approves drug to treat aggressive medullary thyroid cancer
After an international, double-blind clinical trial conducted among patients with advanced medullary thyroid cancer, the U.S. Food and Drug Administration (FDA) recently approved a medication called vandetanib to treat the disease.
SHOW MAIN MENU
SHOW SUB MENU